Röhmel J
Federal Institute for Drugs and Medical Devices, Berlin, Germany.
Stat Med. 1998;17(15-16):1703-14. doi: 10.1002/(sici)1097-0258(19980815/30)17:15/16<1703::aid-sim972>3.0.co;2-g.
Therapeutic equivalence studies still present problems to regulatory reviewers from many perspectives. This paper is intended to discuss some of these concerns from the statistical viewpoint. There are, however, also some newer approaches which may be particularly useful for the investigation of therapeutic equivalence.
治疗等效性研究从许多角度来看仍然给监管审评人员带来问题。本文旨在从统计学角度讨论其中一些问题。然而,也有一些更新的方法可能对治疗等效性的研究特别有用。